Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Clinical trial NCT02027428 · COMPLETED

Trial details

NCT number: NCT02027428
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma, Non-Small-Cell Lung

Start date: 2014-02-11
Primary completion: 2017-09-15
Enrollment: 427

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.